Transdermal formulations, methods and devices
March 26, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3598122 3598123 Device consisting of copolymer having acetoxy groups for delivering drugs Therapeutic system for administering drugs to the skin Dissolution controlled active agent dispenser Dosage for coadministering drug and percutaneous absorption enhancer Skin permeation enhancer compositions Skin permeation enhancer compositions using glycerol monolaurate Transdermal contraceptive formulations Skin permeation enhancer compositions using glycerol monooleate Patent #: 4863738 InventorsApplicationNo. 039593 filed on 03/26/1993US Classes:424/448, Pressure sensitive adhesive means424/447, Bandages with incorporated medicaments424/449, Transdermal or percutaneous514/946, PENETRANT OR ABSORBENT (ENHANCES PENETRATION INTO SUBJECT TREATED)514/947Topical applicationExaminersPrimary: Phelan, D. GabrielleAttorney, Agent or FirmForeign Patent References
International ClassA61F 013/02AbstractThe present invention provides compositions and methods for the transdermal administration of a therapeutically effective amount of a synthetic 19-nor-progesterone (ST-1435) and an estrogen, in combination, together with, optionally, a suitable permeation enhancer.Other References
| |
